IL128329A - Pharmaceutical composition of hedgehog proteins and use thereof - Google Patents

Pharmaceutical composition of hedgehog proteins and use thereof

Info

Publication number
IL128329A
IL128329A IL12832999A IL12832999A IL128329A IL 128329 A IL128329 A IL 128329A IL 12832999 A IL12832999 A IL 12832999A IL 12832999 A IL12832999 A IL 12832999A IL 128329 A IL128329 A IL 128329A
Authority
IL
Israel
Prior art keywords
carrier
hedgehog protein
pharmaceutical composition
hedgehog
negatively
Prior art date
Application number
IL12832999A
Other languages
English (en)
Other versions
IL128329A0 (en
Original Assignee
Curis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curis Inc filed Critical Curis Inc
Publication of IL128329A0 publication Critical patent/IL128329A0/xx
Publication of IL128329A publication Critical patent/IL128329A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12832999A 1998-02-04 1999-02-02 Pharmaceutical composition of hedgehog proteins and use thereof IL128329A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98101893 1998-02-04
EP98104416 1998-03-12

Publications (2)

Publication Number Publication Date
IL128329A0 IL128329A0 (en) 2000-01-31
IL128329A true IL128329A (en) 2005-08-31

Family

ID=26149005

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12832999A IL128329A (en) 1998-02-04 1999-02-02 Pharmaceutical composition of hedgehog proteins and use thereof

Country Status (14)

Country Link
JP (1) JP3092706B2 (fr)
KR (2) KR19990072406A (fr)
CN (1) CN1228994A (fr)
AT (1) ATE331533T1 (fr)
AU (1) AU713568B2 (fr)
CA (1) CA2260423C (fr)
CZ (1) CZ33799A3 (fr)
DE (1) DE69932113T2 (fr)
HU (1) HUP9900251A3 (fr)
IL (1) IL128329A (fr)
MA (1) MA26602A1 (fr)
NO (1) NO990471L (fr)
NZ (1) NZ334065A (fr)
SG (1) SG66504A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
KR100452752B1 (ko) * 2000-04-18 2004-10-12 주식회사 펩트론 단백질 함유 서방성 제제를 제조하는 방법 및 그 제제
KR101705323B1 (ko) * 2010-03-23 2017-02-13 코웨이 주식회사 역삼투막 방식의 정수기
KR102176832B1 (ko) * 2017-11-29 2020-11-10 주식회사 파이안바이오테크놀로지 헤지호그 단백질 및 생체 적합성 물질을 포함하는 미세 입자 및 이를 포함하는 탈모 예방 또는 치료용 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866165A (en) 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair

Also Published As

Publication number Publication date
DE69932113D1 (de) 2006-08-10
KR19990072423A (ko) 1999-09-27
CA2260423A1 (fr) 1999-08-04
IL128329A0 (en) 2000-01-31
JP3092706B2 (ja) 2000-09-25
SG66504A1 (en) 2000-07-18
NO990471L (no) 1999-08-05
CZ33799A3 (cs) 1999-08-11
DE69932113T2 (de) 2007-01-25
CA2260423C (fr) 2006-06-20
HUP9900251A2 (hu) 1999-09-28
MA26602A1 (fr) 2004-12-20
HUP9900251A3 (en) 2001-01-29
NO990471D0 (no) 1999-02-01
AU713568B2 (en) 1999-12-02
NZ334065A (en) 2000-06-23
ATE331533T1 (de) 2006-07-15
AU1542699A (en) 1999-08-26
HU9900251D0 (en) 1999-03-29
KR19990072406A (ko) 1999-09-27
JP2000119193A (ja) 2000-04-25
CN1228994A (zh) 1999-09-22
KR100311565B1 (ko) 2001-11-02

Similar Documents

Publication Publication Date Title
AU9036598A (en) Methods and compositions to prevent formation of adhesions in biological tissues
CA2329768A1 (fr) Composition pharmaceutique a base de facteur viii et de liposomes neutres
AU8700898A (en) Bioresorbable compositions for implantable prostheses
EP2266590A3 (fr) Système d'administration de substances actives et méthodes de protection et d'administration de substances actives
CA2239775A1 (fr) Composition a base de polymeres reticules et leur procede d'utilisation
EP1354598A3 (fr) Procédés d'utilisation thérapeutique des récepteurs solubles BR43x2
EP1577670A3 (fr) Polymère réactive latente avec des groupements biologiques actives.
TWI255721B (en) Absorbable microparticles
WO1997026864A3 (fr) Procedes et compositions permettant de renforcer les proprietes bioadhesives de polymeres
JP2003525916A5 (fr)
WO1995024430A3 (fr) Copolymeres en blocs et greffes, et procedes les concernant
WO1998035703A3 (fr) Procedes et compositions permettant d'apporter des agents therapeutiques a des tissus osseux a l'aide de conjugues d'oligomeres peptidiques charges negativement et d'agents therapeutiques
CA2251281A1 (fr) Preparation pharmaceutique a taux de liberation programme
AU7808700A (en) Zwitterionic polymer blend materials
CA2287534A1 (fr) Microparticules biodegradables pour administration soutenue de medicaments therapeutiques
AU8067198A (en) Compositions for delivery of biological agents and methods for the preparation thereof
ATE208369T1 (de) Neue lipopolyamine, deren darstellung und anwendung
IL128329A (en) Pharmaceutical composition of hedgehog proteins and use thereof
WO1996028468A3 (fr) Peptides amphiphiles et analogues desdits peptides
ES2153648T3 (es) Polimeros con estado fisico y bioerosionabilidad controlados.
WO1991003226A3 (fr) Compositions pharmaceutiques contenant des polymeres aromatiques et procedes therapeutiques les employant
CA2225998A1 (fr) Preparations de genes contenant un materiau biocompatible pour la liberation continue dans le cadre d'une therapie genique
WO2000063366A3 (fr) Oligomeres antisens perfectionnes
ECSP992851A (es) Composiciones farmaceuticas de proteinas erizo y uso de las mismas
WO1996040273A3 (fr) Conjugues de ferrite et d'oligonucleotides qui se lient specifiquement a certaines structures cibles

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed